Phibro Animal Health | PAHC - Spese Operative





Spese Operative Cambiamento Data
Align Technology USD 822.85M 11.8M 2025-12
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Corcept Therapeutics USD 197.64M 219K 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Henry Schein USD 3.25B 110M 2025-12
Idexx Laboratories USD 774.97M 24.58M 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Merck USD 10.16B 558M 2025-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Pacira USD 193.68M 27.32M 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Zoetis USD 1.55B 3.85B 2025-12